Pulmonx LUNG
NASDAQ LUNG
$1.88 -0.10 (-5.05%)
As of: Sep 10, 2026 · 3:18 PM EDT

Pulmonx (LUNG) Net Margin (2019 - 2025)

Pulmonx's (LUNG) quarterly Net Margin came in at 64.91% in Q3 2025, up 451.0% year-over-year from 11.78% in Q3 2024, and down 1.91% quarter-over-quarter from 63.69% in Q2 2025.

Analysis

Pulmonx (LUNG) Net Margin (2019 - 2025) Analysis & Trends

Pulmonx (LUNG) has reported Net Margin for 7 consecutive years, with 64.91% the latest figure, recorded in Q3 2025.

  • On a quarterly basis, Net Margin rose 451.0% year-over-year to 64.91% in Q3 2025; TTM through Sep 2025 was 61.9%, a 1016.0% increase from a year earlier, with the FY2024 full-year figure at 67.3%, up 2129.0% from the prior year.
  • Net Margin was 64.91% for Q3 2025 at Pulmonx, down from 63.69% in the prior quarter.
  • Over five years, Net Margin peaked at 55.28% in Q4 2024 and troughed at 147.07% in Q1 2022.
  • A 5-year average of 88.81% and a median of 84.57% in 2023 frame the typical range for Net Margin.
  • The widest YoY moves for Net Margin: up 21910 bps in 2021, down 5259 bps in 2021.
  • Over 5 years, Net Margin stood at 94.81% in 2021, then grew by 2 bps to 92.6% in 2022, then rose by 22 bps to 72.04% in 2023, then grew by 23 bps to 55.28% in 2024, then dropped by 17 bps to 64.91% in 2025.
  • The last three Net Margin figures came in at 64.91% (Q3 2025), 63.69% (Q2 2025), and 64.11% (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 180.08 Bn 174.48 Bn 7.27 Bn 7.37%
2 Intuitive Surgical 127.86 Bn 122.64 Bn 1.96 Bn 28.46%
3 Medtronic 117.15 Bn 108.33 Bn 6.34 Bn 15.17%
4 Stryker 103.82 Bn 100.34 Bn 4.50 Bn 19.37%
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 16.67%
6 Edwards Lifesciences 49.76 Bn 45.51 Bn 1.35 Bn 13.87%
7 Alcon 32.95 Bn 31.49 Bn 1.68 Bn -
8 Dexcom 32.22 Bn 30.27 Bn 830.00 Mn 19.04%
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn 13.47%
10 Pulmonx 76.96 Mn 7.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -64.91%
Jun 30, 2025 -63.69%
Mar 31, 2025 -64.11%
Dec 31, 2024 -55.28%
Sep 30, 2024 -69.42%
Jun 30, 2024 -73.82%
Mar 31, 2024 -73.00%
Dec 31, 2023 -72.04%
Sep 30, 2023 -84.57%
Jun 30, 2023 -94.19%
Mar 31, 2023 -109.12%
Dec 31, 2022 -92.60%
Sep 30, 2022 -104.96%
Jun 30, 2022 -104.95%
Mar 31, 2022 -147.07%
Dec 31, 2021 -94.81%
Sep 30, 2021 -76.77%
Jun 30, 2021 -106.38%
Mar 31, 2021 -135.71%
Dec 31, 2020 -94.50%